Form 4 for BURU Nuburu, Inc.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0000899243-23-003767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-01-31 | BURU | Zediker Mark | CEO, Dir, 10% | A - Grant | — | +4.31M | 4.31M | New | — |
| D | 2023-02-02 | 2023-01-31 | BURU | Zediker Mark | CEO, Dir, 10% | A - Grant | — | +998.9K | 998.9K | New | — |
| DI | 2023-02-02 | 2023-01-31 | BURU | Zediker Mark | CEO, Dir, 10% | A - Grant | — | +5,153 | 5,153 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | A | A | 4,308,203 | — | 4,308,203 | D | — | — | (F2) In connection with the closing of the Business Combination, each share of Legacy Nuburu common stock, par value $0.0001 per share ("Legacy Nuburu Common Stock"), issued and outstanding immediately prior to the effective time of the merger was canceled and converted into the right to receive the number of shares of Common Stock of the Issuer equal to an exchange ratio calculated at closing (the "Common Stock Exchange Ratio"). |
| 2 | Derivative | Stock Option (right to buy) | 2023-01-31 | A | A | 998,946 | — | 998,946 | D See footnote | $4.86 · 2021-08-01 to 2030-10-20 | 998,946 Common Stock | (F4) In connection with the closing of the Business Combination, each outstanding option to purchase shares of Legacy Nuburu Common Stock, whether vested or unvested, was exchanged for comparable options to purchase Common Stock based on the Common Stock Exchange Ratio. (F6) The option is held directly by Dr. Zediker's spouse. Dr. Zediker may be deemed to share voting and investment control over the option; however, Dr. Zediker disclaims beneficial ownership of the option except to the extent of his pecuniary interest therein. (F3) 1/4th of the shares subject to the option became vested and exercisable on the Exercisable Date set forth above, and 1/48th vested or will vest each month thereafter on the same day of the month subject to Dr. Zediker continuing to serve as a service provider to the Issuer through the applicable vesting date. |
| 3 | Derivative | Stock Option (right to buy) | 2023-01-31 | A | A | 5,153 | — | 5,153 | I | $1.36 · 2018-04-01 to 2027-04-26 | 5,153 Common Stock | (F4) In connection with the closing of the Business Combination, each outstanding option to purchase shares of Legacy Nuburu Common Stock, whether vested or unvested, was exchanged for comparable options to purchase Common Stock based on the Common Stock Exchange Ratio. (F5) 100% of the shares subject to the option became vested and exercisable on the Exercisable Date set forth above. |